A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell Lymphoma

Baskaran Subramani
, Patrick J. Conway
, Aisha Al-Khinji
, Kun Zhang
, Ritu Pandey
, Daruka Mahadevan

Producción científica: Article › revisión exhaustiva

Clasificar por

Pharmacology, Toxicology and Pharmaceutical Science